Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2012 (2012), Article ID 237482, 8 pages
http://dx.doi.org/10.1155/2012/237482
Research Article

Cyprinus carpio Decoction Improves Nutrition and Immunity and Reduces Proteinuria through Nephrin and CD2AP Expressions in Rats with Adriamycin-Induced Nephropathy

1Department of Nutrition, Tianjin Third Central Hospital, Tianjin 300170, China
2Tianjin Key Laboratory of Artificial Cells, Tianjin Third Central Hospital, Tianjin 300170, China
3Department of Nutrition, Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300000, China
4Institute of Integrative medicine, Qingdao University Medical College, Qingdao 266021, China
5Department of Nutrition, The First Affiliated Hospital of Soochow University, Jiangsu, Suzhou 215000, China

Received 29 November 2011; Revised 3 March 2012; Accepted 19 March 2012

Academic Editor: Cheorl-Ho Kim

Copyright © 2012 Yumei Qi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. L. Li and Z. H. Liu, Chinese Nephrology, People’s Military Medical Press, Beijing, China, 2008.
  2. M. G. Chen, R. X. Lin, Q. Yang et al., “The protective effect of rehmannia glutinosa libosch extract on kidney of adriamycin nephrotic rats,” Chinese Archives of Traditional Chinese Medicine, vol. 27, no. 10, pp. 2114–2116, 2009. View at Google Scholar
  3. M. G. Wei, L. Zhang, J. D. Shao et al., “Analysis of basic pathogenesis of chronic renal disease and experimental study of Jiawei Danggui Buxue Tang on adriamycin renal disease rats,” China Journal of Traditional Chinese Medicine and Pharmacy, vol. 26, no. 5, pp. 1211–1216, 2011. View at Google Scholar
  4. V. W. Lee and D. C. Harris, “Adriamycin nephropathy: a model of focal segmental glomerulosclerosis,” Nephrology, vol. 16, no. 1, pp. 30–38, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. M. A. Alvarez-Lara, J. Carracedo, R. Ramírez et al., “The imbalance in the ratio of Th1 and Th2 helper lymphocytes in uraemia is mediated by an increased apoptosis of Th1 subset,” Nephrology Dialysis Transplantation, vol. 19, no. 12, pp. 3084–3090, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. J. C. Peterson, S. Adler, J. M. Burkart et al., “Blood pressure control, proteinuria, and the progression of renal disease: the modification of diet in renal disease study,” Annals of Internal Medicine, vol. 123, no. 10, pp. 754–762, 1995. View at Google Scholar · View at Scopus
  7. J. Lea, T. Greene, L. Hebert et al., “The relationship between magnitude of proteinuria reduction and risk of end-stage renal disease: results of the African American study of kidney disease and hypertension,” Archives of Internal Medicine, vol. 165, no. 8, pp. 947–953, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. S. S. Chugh, B. Kaw, and Y. S. Kanwar, “Molecular structure-function relationship in the slit diaphragm,” Seminars in Nephrology, vol. 23, no. 6, pp. 544–555, 2003. View at Google Scholar · View at Scopus
  9. N. Y. Shi, J. Li, R. Cotran, P. Mundel, J. H. Miner, and A. S. Shaw, “CD2AP localizes to the slit diaphragm and binds to nephrin via a novel C-terminal domain,” American Journal of Pathology, vol. 159, no. 6, pp. 2303–2308, 2001. View at Google Scholar · View at Scopus
  10. S. Z. Li, Compendium of Materia Medica, People’s Military Medical Press, Beijing, China, 2005.
  11. Y. You, Jin Kui Yi, China Press of Traditional Chinese Medicine, Beijing, China, 1996.
  12. S. M. Sun, Essential Recipes for Emergent Use Worth a Thousand Gold, Chinese Ancient Books, Beijing, China, 1999.
  13. T. Wang, Medical Secrets of an Official, People’s Military Medical Press, Beijing, China, 1987.
  14. H. Y. Wang, Taiping Prescription of Holy Benevolence, People’s Military Medical Press, Beijing, China, 1982.
  15. J. Pan, “The clinical experience of the treatment on proteinuria from chronic nephritis by Professor Jinghuan Guan,” Chinese Journal of Integrated Traditional and Western Nephrology, vol. 5, no. 8, pp. 438–439, 2004. View at Google Scholar
  16. P. G. Li and J. H. Yang, “Li Yu Chi Xiao Dou tang cure severe edema,” Journal of New Chinese Medicine, vol. 2, no. 9, p. 59, 1982. View at Google Scholar
  17. H. Y. Liu, K. S. Zhang, and Y. X. Ren, “Preparation of antioxidant peptide from common carp myofibrillar protein by enzymatic hydrolysis,” Food Research And Development, vol. 32, no. 8, pp. 26–30, 2011. View at Google Scholar
  18. S. A. Doggrell, “ACE inhibitors and AT-1-receptor antagonists COOPERATE in non-diabetic renal disease,” Expert Opinion on Pharmacotherapy, vol. 4, no. 7, pp. 1185–1188, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. N. Nakao, A. Yoshimura, H. Morita, M. Takada, T. Kayano, and T. Ideura, “Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial,” The Lancet, vol. 361, no. 9352, pp. 117–124, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. M. W. Taal and B. M. Brenner, “Combination ACEI and ARB therapy: additional benefit in renoprotection?” Current Opinion in Nephrology and Hypertension, vol. 11, no. 4, pp. 377–381, 2002. View at Publisher · View at Google Scholar · View at Scopus
  21. K. Chang, B. Lv, B. S. Zhong et al., “Carpio Decoction removed proteinuria in nephritic syndrome,” Modern Journal of Integrated Chinese Traditional and Western Medicine, vol. 10, no. 16, pp. 1536–1537, 2001. View at Google Scholar
  22. X. J. Tian, J. S. Yu, Y. L. Guo et al., “The effect of Cyprinus carpio Decoction on proteinuria of adriamycin nephropathy rats,” Journal of Medicine Research, vol. 40, no. 4, pp. 37–39, 2011. View at Google Scholar
  23. T. Bertani, A. Poggi, and R. Pozzoni, “Adriamycin-induced nephrotic syndrome in rats. Sequence of pathologic events,” Laboratory Investigation, vol. 46, no. 1, pp. 16–23, 1982. View at Google Scholar · View at Scopus
  24. K. Kalantar-Zadeh, P. Stenvinkel, L. Pillon, and J. D. Kopple, “Inflammation and Nutrition in Renal Insufficiency,” Advances in Renal Replacement Therapy, vol. 10, no. 3, pp. 155–169, 2003. View at Google Scholar · View at Scopus
  25. B. M. R. Spiegel, G. Melmed, S. Robbins, and E. Esrailian, “Biomarkers and health-related quality of life in end-stage renal disease: a systematic review,” Clinical Journal of the American Society of Nephrology, vol. 3, no. 6, pp. 1759–1768, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. Q. Q. Ding, S. N. Kong, and J. F. Zheng, “The relationship between nutrition status and renal function in renal disease patients,” Parenteral & Enteral Nutrition, vol. 10, no. 7, pp. 154–155, 2003. View at Google Scholar
  27. T. J. Neuhaus, M. Wadhwa, R. Callard, and T. M. Barratt, “Increased IL-2, IL-4 and interferon-gamma (IFN-γ) in steroid-sensitive nephrotic syndrome,” Clinical and Experimental Immunology, vol. 100, no. 3, pp. 475–479, 1995. View at Google Scholar · View at Scopus
  28. H. Wang, C. Yang, and Y. Mao, “The relationship of interleukin-4 and interferon- γ with steroid effect in children with primary nephrotic syndrome,” Journal of Xi'an Jiaotong University (Medical Sciences), vol. 27, no. 5, pp. 483–485, 2006. View at Google Scholar · View at Scopus
  29. W. Coers, J. T. W. M. Vos, P. H. Van Der Meide, M. L. C. Van Der Horst, S. Huitema, and J. J. Weening, “Interferon-gamma (IFN-γ) and IL-4 expressed during mercury-induced membranous nephropathy are toxic for cultured podocytes,” Clinical and Experimental Immunology, vol. 102, no. 2, pp. 297–307, 1995. View at Google Scholar · View at Scopus
  30. Z. M. Wang, Q. Jing, X. Y. Hu et al., “The activity measurement of serum interferon-gamma in children with idiopathic nephrotic syndrome,” Chinese Journal of Pediatrics, vol. 38, no. 5, pp. 320–321, 2000. View at Google Scholar
  31. J. Stachowski, C. Barth, J. Michałkiewicz et al., “Th1/Th2 balance and CD45-positive T cell subsets in primary nephrotic syndrome,” Pediatric Nephrology, vol. 14, no. 8-9, pp. 779–785, 2000. View at Google Scholar · View at Scopus
  32. J. G. Van Den Berg, J. Aten, M. A. Chand et al., “Interleukin-4 and interleukin-13 act on glomerular visceral epithelial cells,” Journal of the American Society of Nephrology, vol. 11, no. 3, pp. 413–422, 2000. View at Google Scholar · View at Scopus
  33. K. Zandi-Nejad, A. A. Eddy, R. J. Glassock, and B. M. Brenner, “Why is proteinuria an ominous biomarker of progressive kidney disease?” Kidney International, Supplement, vol. 66, no. 92, pp. S76–S89, 2004. View at Publisher · View at Google Scholar · View at Scopus
  34. G. Remuzzi and T. Bertani, “Pathophysiology of progressive nephropathies,” The New England Journal of Medicine, vol. 339, no. 20, pp. 1448–1456, 1998. View at Publisher · View at Google Scholar · View at Scopus
  35. S. Somlo and P. Mundel, “Getting a foothold in nephrotic syndrome,” Nature Genetics, vol. 24, no. 4, pp. 333–335, 2000. View at Publisher · View at Google Scholar · View at Scopus
  36. D. Kerjaschki, “Caught flat-footed: podocyte damage and the molecular bases of focal glomerulosclerosis,” The Journal of Clinical Investigation, vol. 108, no. 11, pp. 1583–1587, 2001. View at Publisher · View at Google Scholar · View at Scopus
  37. M. Kestilä, U. Lenkkeri, M. Männikkö et al., “Positionally cloned gene for a novel glomerular protein—nephrin—is mutated in congenital nephrotic syndrome,” Molecular Cell, vol. 1, no. 4, pp. 575–582, 1998. View at Google Scholar · View at Scopus
  38. K. Tryggvason, J. Patrakka, and J. Wartiovaara, “Hereditary proteinuria syndromes and mechanisms of proteinuria,” The New England Journal of Medicine, vol. 354, no. 13, pp. 1387–1401, 2006. View at Publisher · View at Google Scholar · View at Scopus
  39. N. Boute, O. Gribouval, S. Roselli et al., “NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome,” Nature Genetics, vol. 24, no. 4, pp. 349–354, 2000. View at Publisher · View at Google Scholar · View at Scopus
  40. H. Yuan, E. Takeuchi, G. A. Taylor, M. Mclaughlin, D. Brown, and D. J. Salant, “Nephrin dissociates from actin, and its expression is reduced in early experimental membranous nephropathy,” Journal of the American Society of Nephrology, vol. 13, no. 4, pp. 946–956, 2002. View at Google Scholar · View at Scopus
  41. A. Benigni, S. Tomasoni, E. Gagliardini et al., “Blocking angiotensin II synthesis/activity preserves glomerular nephrin in rats with severe nephrosis,” Journal of the American Society of Nephrology, vol. 12, no. 5, pp. 941–948, 2001. View at Google Scholar · View at Scopus
  42. K. Schwarz, M. Simons, J. Reiser et al., “Podocin, a raft-associated component of the glomerular slit diaphragm, interacts with CD2AP and nephrin,” The Journal of Clinical Investigation, vol. 108, no. 11, pp. 1621–1629, 2001. View at Publisher · View at Google Scholar · View at Scopus
  43. N. Y. Shih, J. Li, V. Karpitskii et al., “Congenital nephrotic syndrome in mice lacking CD2-associated protein,” Science, vol. 286, no. 5438, pp. 312–315, 1999. View at Publisher · View at Google Scholar · View at Scopus